Çocuklarda Kabızlık Nedeni Olan Gastrointestinal Sistem Hastalıkları
Referanslar
Harvey S, Matthai S, King DA. How to use the Bristol Stool Chart in childhood constipation.
Arch Dis Child Educ Pract Ed. 2023;108(5):335-339. doi:10.1136/archdischild-2022-324513
Mulhem E, Khondoker F, Kandiah S. Constipation in Children and Adolescents: Evaluation and Treatment. Am Fam Physician. 2022;105(5):469-478.
Nurko S, Zimmerman LA. Evaluation and treatment of constipation in children and adoles- cents. Am Fam Physician. 2014;90(2):82-90.
Tabbers MM, DiLorenzo C, Berger MY. Evaluation and treatment of functional constipation in infants and children: evidence-based recommendations from ESPGHAN and NASPGHAN. J Pediatr Gastroenterol Nutr. 2014;58(2):258-274. doi:10.1097/MPG.0000000000000266
Small Intestinal Bacterial Overgrowth Classic Articles in Colonic and Rectal Surgery. Constipa- tion in the newborn as a result of dilation and hypertrophy of the colon: Harald Hirschsprung, Jahrbuch für Kinderheilkunde, 1888. Dis Colon Rectum. 1981;24(5):408-410.
SWENSON O, BILL AHJ. Resection of rectum and rectosigmoid with preservation of the sphincter for benign spastic lesions producing megacolon; an experimental study. Surgery. 1948;24(2):212-220.
Amiel J, Sproat-Emison E, Garcia-Barcelo M. Hirschsprung disease, associated syndromes and genetics: a review. J Med Genet. 2008;45(1):1-14. doi:10.1136/jmg.2007.053959
Pashankar DS. Childhood constipation: evaluation and management. Clin Colon Rectal Surg. 2005;18(2):120-127. doi:10.1055/s-2005-870894
Kessmann J. Hirschsprung’s disease: diagnosis and management. Am Fam Physician. 2006;74(8):1319-1322.
Moore SW. Total colonic aganglionosis in Hirschsprung disease. Semin Pediatr Surg. 2012;21(4):302-309. doi:10.1053/j.sempedsurg.2012.07.004
McCallion AS. Phenotype variation in two-locus mouse models of Hirschsprung disease: tis- sue-specific interaction between Ret and Ednrb. Proc Natl Acad Sci U S A. 2003;100(4):1826- 1831. doi:10.1073/pnas.0337540100
Gfroerer S, Rolle U. Pediatric intestinal motility disorders. World J Gastroenterol. 2015;21(33):9683-9687. doi:10.3748/wjg.v21.i33.9683
Gershon EM. Hirschsprung’s disease associated enterocolitis: A comprehensive review. World J Clin Pediatr. 2023;12(3):68-76. doi:10.5409/wjcp.v12.i3.68
Musa ZA. Diagnostic roles of calretinin in hirschsprung disease: A comparison to neuron-spe- cific enolase. Saudi J Gastroenterol. 2017;23(1):60-66. doi:10.4103/1319-3767.199118
Tou JF, Li MJ. Mutation of RET proto-oncogene in Hirschsprung’s disease and intestinal neuro- nal dysplasia. World J Gastroenterol. 2006;12(7):1136-1139. doi:10.3748/wjg.v12.i7.1136
Terra SA. A critical appraisal of the morphological criteria for diagnosing intestinal neuronal dysplasia type B. Modern Pathology. 2017;30(7):978-985.
Kapur RP, Reyes-Mugica M. Intestinal Neuronal Dysplasia Type B: An Updated Review of a Problematic Diagnosis. Arch Pathol Lab Med. 2019;143(2):235-243. doi:10.5858/arpa.2017- 0524-RA
Thapar N. Paediatric Intestinal Pseudo-obstruction: Evidence and Consensus-based Re- commendations From an ESPGHAN-Led Expert Group. J Pediatr Gastroenterol Nutr. 2018;66(6):991-1019. doi:10.1097/MPG.0000000000001982
Wood RJ, Levitt MA. Anorectal Malformations. Clin Colon Rectal Surg. 2018;31(2):61-70. do- i:10.1055/s-0037-1609020
Smith CA, Avansino J. Anorectal Malformations. In: StatPearls [Internet]. StatPearls Publis- hing; 2023.
Hakalmaz AE, Topuzlu Tekant G. Anorectal Malformations and Late-Term Problems. Turk Arch Pediatr. 2023;58(6):572-579. doi:10.5152/TurkArchPediatr.2023.23090
Connor F. Cows’ Milk Allergy-Associated Constipation: When to Look for It? A Narrative Re- view. Nutrients. 2022;14(6):1317. doi:10.3390/nu14061317
Isa HM. Assessing indicators and clinical differences between functional and organic childho- od constipation: a retrospective study in pediatric gastroenterology clinics. Clin Exp Pediatr. 2023;66(7):296-306. doi:10.3345/cep.2022.01298
Dehghani SM. The Role of Cow’s Milk Allergy in Pediatric Chronic Constipation: A Randomi- zed Clinical Trial. Iran J Pediatr. 2012;22(4):468-474.
Chugh AA. Celiac Disease. In: Kliegman RM, St. Geme JW, eds. Nelson Textbook of Pediatrics. Elsevier; 2024.
Pelleboer RAA. Celiac disease is overrepresented in patients with constipation. J Pediatr (Rio J). 2012;88(2):173-176.
Leung AK, Hon KL. Paediatrics: how to manage functional constipation. Drugs Context. 2021;10. doi:10.7573/dic.2020-11-2
Meena M. Prevalence and Predictors of Celiac Disease in Children With Constipation. Indian Pediatr. 2024;61(4):331-336.
Lebwohl B, Green PHR. Celiac Disease. In: Sleisenger and Fordtran’s Gastrointestinal and Liver Disease. Elsevier; 2021.
De Giorgio R. Chronic intestinal pseudo-obstruction: clinical features, diagnosis, and therapy.
Gastroenterol Clin North Am. Published online 2011.
Tang X. Pathophysiological mechanisms, diagnostic innovations, and multimodal therapeu- tic strategies for slow transit constipation. BMC Gastroenterol. 2025;25(1):810. doi:10.1186/ s12876-025-04387-9
Husby S. ESPGHAN Guidelines for Diagnosing Coeliac Disease. J Pediatr Gastroenterol Nutr. 2020;70(1):141-156.
Leffler DA. Celiac Disease. In: Yamada’s Textbook of Gastroenterology. Wiley-Blackwell; 2022.
Cil O. CFTR activator increases intestinal fluid secretion and normalizes stool output in a mou- se model of constipation. Cell Mol Gastroenterol Hepatol. 2016;2(3):317-327. doi:10.1016/j.jcm- gh.2015.12.010
Adeyemo-Salami OA. Cystic fibrosis in the intestine and the influence on digestion. J Immunol Sci. Published online 2020. doi:10.29245/2578-3009/2020/3.1187
De Lisle RC, Borowitz D. The cystic fibrosis intestine. Cold Spring Harb Perspect Med. 2013;3(9). doi:10.1101/cshperspect.a009753
Fernández-Ibieta M. Treatment options of distal intestinal obstruction syndrome: And if the ene- mas fail? An Pediatr (Barc). 2016;84(1):54-55. doi:10.1016/j.anpede.2015.05.021
Anton-Păduraru DT. Diagnosis and Management of Gastrointestinal Manifestations in Child- ren with Cystic Fibrosis. Diagnostics. 2024;14(2):228. doi:10.3390/diagnostics14020228
Miles C. Presentation, characteristics and management of obstructive intestinal conditions in cystic fibrosis. Frontline Gastroenterol. 2024;15(3):222-227. doi:10.1136/flgastro-2023-102533
van der Doef HP. Intestinal obstruction syndromes in cystic fibrosis: meconium ileus, distal in- testinal obstruction syndrome, and constipation. Curr Gastroenterol Rep. 2011;13(3):265-270. doi:10.1007/s11894-011-0185-9
Adu Y. Adult intussusception of the small intestine caused by cystic fibrosis: a case report, re- view of the literature, and guide for management. J Surg Case Rep. 2023;(10). doi:10.1093/jscr/ rjad574
Somaraju URR. Pancreatic enzyme replacement therapy for people with cystic fibrosis. Cochra- ne Database Syst Rev. 2020;8(8). doi:10.1002/14651858.CD008227.pub4
Houwen RH. Defining DIOS and constipation in cystic fibrosis with a multicentre study on the incidence, characteristics, and treatment of DIOS. J Pediatr Gastroenterol Nutr. 2010;50(1).
Kruger Howard A. Evaluation of Polyethylene Glycol Dosing for Functional Constipation in Children. Hosp Pharm. 2024;59(6):645-649. doi:10.1177/00185787241257390
O’Brien CE. Lubiprostone for constipation in adults with cystic fibrosis: a pilot study. Ann Pharmacother. 2011;45(9):1061-1066. doi:10.1345/aph.1Q219
Velez A. Safety and effectiveness of prucalopride in children with functional constipation with and without upper symptoms. Pediatr Drugs. Published online 2024. doi:10.1007/s40272-023- 00612-8
Cruz Mosquera FE. Effectiveness of Probiotics, Prebiotics, and Symbiotic Supplementation in Cystic Fibrosis Patients: A Systematic Review and Meta-Analysis of Clinical Trials. Medicina (Kaunas). 2025;61(3):489. doi:10.3390/medicina61030489
Schwarzenberg SJ. Elexacaftor/tezacaftor/ivacaftor and gastrointestinal outcomes in cystic fibrosis: Report of promise-GI. J Cyst Fibros. 2023;22(2):282-289. doi:10.1016/j.jcf.2022.10.003
Odofin A. Intestinal obstruction in cystic fibrosis: a surgeon’s perspective. International Surgery Journal. 2018;5(9):2948-2951. doi:10.18203/2349-2902.isj20183712
Miller C. Constipation in ulcerative colitis: pathophysiology and practical management. Front- line Gastroenterol. 2021;12:493-499.
Cenni S, Colucci A, Salomone S, et al. The prevalence of constipation in children with new diagnosis of inflammatory bowel disease: A retrospective study. J Pediatr Gastroenterol Nutr. 2025;80(5):799-806. doi:10.1002/jpn3.70005
D’Aleo CM. Childhood Crohn’s disease presenting as chronic constipation. Pediatr Med Chir. 2009;31(4):168-171.
Goday PS. Gastrointestinal disorders: red flags and best treatments. Contemporary PEDS Jour- nal. 2021;38(7).
Al-Beltagi M. Fecal calprotectin in pediatric gastrointestinal diseases: Pros and cons. World J Clin Pediatr. 2024;13(2). doi:10.5409/wjcp.v13.i2.93341
Diefenbach KA. Pediatric inflammatory bowel disease. World J Gastroenterol. 2006;12(20):3204- 3212. doi:10.3748/wjg.v12.i20.3204
Miller C. Constipation in ulcerative colitis: pathophysiology and practical management. Colo- rectal Dis. 2023;25(8). doi:10.1136/flgastro-2020-101566
Neville JJ. Therapeutic strategies for stricturing Crohn’s disease in childhood: a systematic re- view. Pediatr Surg Int. 2021;37(5):569-577. doi:10.1007/s00383-020-04848-0
Sandhu BK. Irritable bowel syndrome in children: pathogenesis, diagnosis and evidence-based treatment. World J Gastroenterol. 2014;20(20):6013-6023. doi:10.3748/wjg.v20.i20.6013
Hawa K. Pediatric irritable bowel syndrome: current understanding and future directions. Curr Treat Options Peds. 2025;11:24. doi:10.1007/s40746-025-00339-3
Karabulut GS. The incidence of irritable bowel syndrome in children using the Rome III cri- teria and the effect of trimebutine treatment. J Neurogastroenterol Motil. 2013;19(1):90-93. doi:10.5056/jnm.2013.19.1.90
Self MM. Subtypes of irritable bowel syndrome in children and adolescents. Clin Gastroenterol Hepatol. 2014;12(9):1468-1473. doi:10.1016/j.cgh.2014.01.031
Reynolds KH. Small intestinal bacterial overgrowth: a case-based review. J Patient Cent Res Rev. 2015;2(4):165-173. doi:10.17294/2330-0698.1209
Ahmed JF. Aetiology, diagnosis and management of small intestinal bacterial overgrowth.
Frontline Gastroenterol. 2023;14(2):149-154. doi:10.1136/flgastro-2022-102163